Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > PET owners in the UK could be wasting up to £600 million each year on prescription-only medicines which provide treatments they don’t actually need, according to new research.
    Finance

    PET owners in the UK could be wasting up to £600 million each year on prescription-only medicines which provide treatments they don’t actually need, according to new research.

    PET owners in the UK could be wasting up to £600 million each year on prescription-only medicines which provide treatments they don’t actually need, according to new research.

    Published by Gbaf News

    Posted on August 7, 2018

    Featured image for article about Finance
    Tags:PET ownerspreferred treatmentprescription

    And now experts have called for better ‘clarity’ on pricing from veterinary surgeries.

     

    Leading pet retailer www.VetUk.co.uk surveyed more than 200 vets in order to work out the average price of flea and tick treatment.

    Through their enquiries they found that veterinary surgeries often have their own ‘preferred treatment’ which they automatically recommend to patients.

    In many cases this preferred, prescription-only treatment is much more expensive than other over-the-counter products, as they also combat other rare parasites such as lungworm and heartworm.

    But Iain Booth, MD of VetUK, says many owners are unaware they’re paying a premium to repel such worms – branding the extra protection potentially ‘unnecessary’.

    And it can push the cost of flea and tick treatment up to an average £139 annually – whereas owners can, in reality, get effective protection for just £30 a year by shopping savvy.

    Calling for better transparency, Mr Booth says: “The majority of vets in the UK will have a preferred product when it comes to treating cats and dogs for fleas and ticks.

    “But many of these products will treat more than just fleas and ticks.

    “So when you are recommended a prescription-only product, you may be unaware your pet is also being treated for lungworm and heartworm – which are both very rare in Britain.

    “It is a treatment you and your pet my not necessarily need.

    “And when you compare this to the standard over-the-counter veterinary flea and tick treatment there is a big price difference.

    “It is rare a pet owner will be asked whether they want this additional treatment, but they’re none-the-wiser, so they end up paying for it regardless.”

    According to recent research, there’s an estimated 20m cat and dog owners, combined, in the UK.

    Around 30 per cent – 6m – regularly take their pet to visit a vet.

    After canvassing costs throughout the UK, vets were recommending flea and tick treatment  – such as Simparica, Bravecto, Broadline and Stronghold – costing an average £126 a year for cats and £139 for medium sized dogs.

    However, budget flea and tick treatments – still containing the active ingredient fipronil, such as VetUK’s own brand – don’t require a prescription and can be purchased for as little as £2.99 per monthly dose for dogs — around £35.97 annually, or £23.40 annually for cats.

    And that equates to combined potential savings among pet owners of more than £600m.

    Mr Booth has also called for pet owners to ask for their pet’s prescription, so they can shop around for medications and treatments.

    He adds: “It is also important to consider that many of these multi-functional medications will be offered for purchase by vets.

    “But owners are well within their rights to ask for a prescription — like they would at their GP — and buy online where the same treatments can be half the price.

    “Keeping an animal is expensive enough when you consider the cost of food and then add other treatments like worming or vaccinations on top.

    “It can be confusing. Vets tend not to publicly list their prices, so there is no way of knowing whether you’re going to get a good deal or not — other than ringing around.

    “Even then, many surgeries won’t divulge their prices unless you are registered with them.

    “And if you want to be registered, a large chunk of these will charge you for a checkup beforehand.

    “That can cost upwards of £30, sometimes nearly £50, depending on where you are in the country.

    “There has to be some kind of clarity or requirement for vets to tell pet owners exactly what they are being treated for, and how it is going to treat their animal.”

    The Royal College of Veterinary Surgeons is responsible for monitoring the profession, and anyone wishing to practice in the UK must be registered.

    But the body has no jurisdiction on fees and accepts cost may vary between practices — and could be a factor in choosing a vet.

    A spokesman added: “The stance of the College is that veterinary practices should take practical steps to set out to their clients in advance charges for things such as consultations, common medicines and routine procedures.

    “As far as the treatment of an animal is concerned making clients aware of expected fees is recommended for gaining informed consent and clients should be informed at the earliest opportunity if fees are likely to increase.”

    For more information on treatment visit https://www.vetuk.co.uk/

    And now experts have called for better ‘clarity’ on pricing from veterinary surgeries.

     

    Leading pet retailer www.VetUk.co.uk surveyed more than 200 vets in order to work out the average price of flea and tick treatment.

    Through their enquiries they found that veterinary surgeries often have their own ‘preferred treatment’ which they automatically recommend to patients.

    In many cases this preferred, prescription-only treatment is much more expensive than other over-the-counter products, as they also combat other rare parasites such as lungworm and heartworm.

    But Iain Booth, MD of VetUK, says many owners are unaware they’re paying a premium to repel such worms – branding the extra protection potentially ‘unnecessary’.

    And it can push the cost of flea and tick treatment up to an average £139 annually – whereas owners can, in reality, get effective protection for just £30 a year by shopping savvy.

    Calling for better transparency, Mr Booth says: “The majority of vets in the UK will have a preferred product when it comes to treating cats and dogs for fleas and ticks.

    “But many of these products will treat more than just fleas and ticks.

    “So when you are recommended a prescription-only product, you may be unaware your pet is also being treated for lungworm and heartworm – which are both very rare in Britain.

    “It is a treatment you and your pet my not necessarily need.

    “And when you compare this to the standard over-the-counter veterinary flea and tick treatment there is a big price difference.

    “It is rare a pet owner will be asked whether they want this additional treatment, but they’re none-the-wiser, so they end up paying for it regardless.”

    According to recent research, there’s an estimated 20m cat and dog owners, combined, in the UK.

    Around 30 per cent – 6m – regularly take their pet to visit a vet.

    After canvassing costs throughout the UK, vets were recommending flea and tick treatment  – such as Simparica, Bravecto, Broadline and Stronghold – costing an average £126 a year for cats and £139 for medium sized dogs.

    However, budget flea and tick treatments – still containing the active ingredient fipronil, such as VetUK’s own brand – don’t require a prescription and can be purchased for as little as £2.99 per monthly dose for dogs — around £35.97 annually, or £23.40 annually for cats.

    And that equates to combined potential savings among pet owners of more than £600m.

    Mr Booth has also called for pet owners to ask for their pet’s prescription, so they can shop around for medications and treatments.

    He adds: “It is also important to consider that many of these multi-functional medications will be offered for purchase by vets.

    “But owners are well within their rights to ask for a prescription — like they would at their GP — and buy online where the same treatments can be half the price.

    “Keeping an animal is expensive enough when you consider the cost of food and then add other treatments like worming or vaccinations on top.

    “It can be confusing. Vets tend not to publicly list their prices, so there is no way of knowing whether you’re going to get a good deal or not — other than ringing around.

    “Even then, many surgeries won’t divulge their prices unless you are registered with them.

    “And if you want to be registered, a large chunk of these will charge you for a checkup beforehand.

    “That can cost upwards of £30, sometimes nearly £50, depending on where you are in the country.

    “There has to be some kind of clarity or requirement for vets to tell pet owners exactly what they are being treated for, and how it is going to treat their animal.”

    The Royal College of Veterinary Surgeons is responsible for monitoring the profession, and anyone wishing to practice in the UK must be registered.

    But the body has no jurisdiction on fees and accepts cost may vary between practices — and could be a factor in choosing a vet.

    A spokesman added: “The stance of the College is that veterinary practices should take practical steps to set out to their clients in advance charges for things such as consultations, common medicines and routine procedures.

    “As far as the treatment of an animal is concerned making clients aware of expected fees is recommended for gaining informed consent and clients should be informed at the earliest opportunity if fees are likely to increase.”

    For more information on treatment visit https://www.vetuk.co.uk/

    Related Posts
    Eni and BlackRock's GIP take joint control of carbon capture unit
    Eni and BlackRock's GIP take joint control of carbon capture unit
    Bank of England's Bailey sees inflation near 2% target by May
    Bank of England's Bailey sees inflation near 2% target by May
    Italian judge drops Genoa dam case against Webuild CEO
    Italian judge drops Genoa dam case against Webuild CEO
    ECB's Lagarde 'fully confident' EU will agree reparation loan plan for Ukraine
    ECB's Lagarde 'fully confident' EU will agree reparation loan plan for Ukraine
    ECB keeps rates unchanged, turns more positive on economy
    ECB keeps rates unchanged, turns more positive on economy
    Austria's top court rules Meta's ad model illegal, orders overhaul of user data practices in EU
    Austria's top court rules Meta's ad model illegal, orders overhaul of user data practices in EU
    Salzgitter takes legal action against Thyssenkrupp over HKM joint venture
    Salzgitter takes legal action against Thyssenkrupp over HKM joint venture
    Lovable valued at $6.6 billion in latest funding round as AI coding demand surges
    Lovable valued at $6.6 billion in latest funding round as AI coding demand surges
    Israel, Germany sign $3.1 billion contract expansion for Arrow air defence system
    Israel, Germany sign $3.1 billion contract expansion for Arrow air defence system
    Britain imposes more sanctions on Russia's energy sector
    Britain imposes more sanctions on Russia's energy sector
    Asked about NATO, Zelenskiy says Ukraine should not change its constitution
    Asked about NATO, Zelenskiy says Ukraine should not change its constitution
    Equals Money | Railsr partners with Okta to secure AI-driven payments
    Equals Money | Railsr partners with Okta to secure AI-driven payments

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Finance

    Explore more articles in the Finance category

    France drafts in army for cattle vaccination to defuse farmer protests

    France drafts in army for cattle vaccination to defuse farmer protests

    Belgian farmers in anti-trade protest clash with police

    Belgian farmers in anti-trade protest clash with police

    UK actors vote to reject digital scans in AI rights push, echoing Hollywood battles

    UK actors vote to reject digital scans in AI rights push, echoing Hollywood battles

    UK pauses trials of Ajax in new setback for army fighting vehicle

    UK pauses trials of Ajax in new setback for army fighting vehicle

    Germany signs $2.35 billion armoured vehicle deal with Finland's Patria

    Germany signs $2.35 billion armoured vehicle deal with Finland's Patria

    ECB keeps rates steady, nudges up growth forecast

    ECB keeps rates steady, nudges up growth forecast

    Lufthansa looks to US flyers opting for premium to boost sales

    Lufthansa looks to US flyers opting for premium to boost sales

    Bank of England policymakers' views on December rate cut

    Bank of England policymakers' views on December rate cut

    EU leaders agree to work on using Russian assets for loan for Ukraine -Polish PM

    EU leaders agree to work on using Russian assets for loan for Ukraine -Polish PM

    ECB holds rates steady and turns more positive on the economy

    ECB holds rates steady and turns more positive on the economy

    Orlen to buy butadiene plant builder from Synthos for $193 million

    Orlen to buy butadiene plant builder from Synthos for $193 million

    British regulator cracks down on home, travel insurers

    British regulator cracks down on home, travel insurers

    View All Finance Posts
    Previous Finance PostFinancial Services: Time to put our bets on “simple”
    Next Finance PostWhat’s an Income Statement?